Koa Shoji News and Activities
Presence
Koa Shoji develops, manufactures, and distributes pharmaceutical products and ingredients. Its main products and services include generic medicines, active pharmaceutical ingredients, and contract manufacturing for healthcare providers and pharmaceutical companies.
Koa Shoji products and services overview:
- Generic medicines
- Pharmaceutical ingredients
- Drug manufacturing
- Drug distribution
- Contract manufacturing
Revenue: ~$180 million
Employees: 850
Headquarters: Yokohama, Japan
Koa Shoji is one of the...
Koa Shoji is a company listed under the stock ticker 9273 (JP).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Koa Shoji
- Toshiyuki Shuto, President, Chairman of Subsidiary and Representat...
- Yuki Yamagishi, Independent Director
- Teruyuki Tanaka, Director
Create your alert
to follow the executive moves at Koa Shoji.
Pharmaceuticals
Koa Shoji has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Koa Shoji
Social media about Koa Shoji
- Koa Shoji on Wikipedia, Google News & Yahoo Finance
- Koa Shoji on LinkedIn, X (Twitter) & YouTube
